Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Super Group (SGHC) Limited Ordinary Shares (SGHC) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Super Group (SGHC) Limited Ordinary SharesTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Super Group (SGHC) Limited Ordinary Shares vs Vir Biotechnology Inc. Common Stock — how do they compare? Super Group (SGHC) Limited Ordinary Shares trades at $11.1 (market cap $5.69B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Super Group (SGHC) Limited Ordinary Shares is far larger — about 3.2× Vir Biotechnology Inc. Common Stock's market cap, and Super Group (SGHC) Limited Ordinary Shares pays a 1.79% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Super Group (SGHC) Limited Ordinary Shares for 6 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

SGHCVIR
Market Cap
$5.69B$1.80B
Volume
2,162,7591,782,836
Sector
Consumer CyclicalHealth
52-Week High
$15.59$11.78
52-Week Low
$8.52$5.12
Typical Hold Time
6 Days0 Days
Enterprise Value
$5.23B$1.36B
Dividend Yield
1.79%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Super Group (SGHC) Limited Ordinary Shares

SGHC trades at $11.19, down 0.27% with a bearish technical signal despite strong fundamentals. The company shows robust profitability with 53.31% gross margins and 48.9% ROE, while revenue grew to $2.23B in 2025. Recent earnings missed expectations but analyst consensus remains unanimously bullish with 8 buy ratings. Technical indicators show selling pressure with moving averages signaling bearish momentum.

SGHC presents a compelling value opportunity with attractive valuation multiples (P/E 15.55, EV/EBITDA 8.43) and strong cash flow generation. However, recent earnings misses and bearish technical signals create near-term headwinds. The stock's outlook depends on Q3 earnings delivery and sustained sports betting momentum amid competitive pressures.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SGHC

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

About Super Group (SGHC) Limited Ordinary Shares

Super Group (SGHC) Limited is a holding company for online sports betting and gaming businesses, operating the Betway sports betting brand and the Spin multi-brand online casino portfolio across markets in Europe, the Americas, and Africa.

Read more on SGHC →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →